EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

NIHR NIFTY (ISRCTN:59074092) randomised controlled trial (RCT) results - does near-infrared fluorescence imaging prevent postsurgical hypoparathyroidism after thyroid surgery?

S P Balasubramanian, J Croft, K Gordon, A Perry, G Ainsworth, N Corrigan, M Twiddy, H Mehanna, L Glenister, N Sharma, J Wadsley, M Strachan und 3 weitere

British Journal of Surgery · 18.05.2026 · 113 (Supplement_3)

DOI: 10.1093/bjs/znag045.013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 18.05.2026. Verfasst von S P Balasubramanian und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-surgical hypoparathyroidism (PoSH) after thyroid surgery has significant short- and long-term morbidity. Near-infrared fluorescence (NIRF) imaging has potential in reducing PoSH incidence.

Methods

A seamless phase II/III (IDEAL 2a-3), unblinded, parallel-group, multicentre RCT was performed in UK NHS patients planned to undergo a total or completion thyroidectomy. Participants were randomised 1:1 to thyroidectomy with NIRF and indocyanine green (NIRF+ICG), or standard thyroidectomy (SC). Operations were performed according to a surgical manual informed by an embedded process evaluation. NIFTy incorporated a phase II analysis using a surrogate primary outcome (1-day hypocalcaemia) to determine early futility of NIRF+ICG, and phase III assessment of the primary outcome of PoSH incidence at 6 months post-surgery. Secondary outcomes included parathyroid hormone levels (key secondary), protracted hypoparathyroidism, hypercalcaemia, complications, length of stay, readmissions and patient reported quality-of-life.

Results

In the phase II analysis, 1-day hypocalcaemia was evaluable in 208/220 patients, occurring in 13/104 (NIRF+ICG) and 17/104 (SC), which demonstrated futility of NIRF+ICG (OR (one-sided 80% CI): 0.734 (0,1.027), p=0.219). After trial closure and follow-up, 6-month PoSH was evaluable in 219/252 randomised participants and occurred in 20/107 (NIRF+ICG) and 14/112 (SC) (OR (95% CI) 0.682 (0.317,1.468)). Safety profiles were similar between arms.

Conclusions

The NIFTY phase II analysis showed that NIRF+ICG was extremely unlikely to demonstrate a significant difference in 6-month PoSH incidence if the trial continued. Detailed trial results, including secondary analyses, will be presented.

Zitieren

APA

Balasubramanian, S. P., Croft, J., Gordon, K., Perry, A., Ainsworth, G., Corrigan, N., Twiddy, M., Mehanna, H., Glenister, L., Sharma, N., Wadsley, J., Strachan, M., Chadwich, D., Jayne, D., & Stocken, D. (2026). NIHR NIFTY (ISRCTN:59074092) randomised controlled trial (RCT) results - does near-infrared fluorescence imaging prevent postsurgical hypoparathyroidism after thyroid surgery?. British Journal of Surgery, 113(Supplement_3). https://doi.org/10.1093/bjs/znag045.013

Vancouver

Balasubramanian SP, Croft J, Gordon K, Perry A, Ainsworth G, Corrigan N, et al. NIHR NIFTY (ISRCTN:59074092) randomised controlled trial (RCT) results - does near-infrared fluorescence imaging prevent postsurgical hypoparathyroidism after thyroid surgery?. British Journal of Surgery. 2026;113(Supplement_3). doi:10.1093/bjs/znag045.013

BibTeX
@article{Balasubramanian2026,
  author = {Balasubramanian, S P and Croft, J and Gordon, K and Perry, A and Ainsworth, G and Corrigan, N and Twiddy, M and Mehanna, H and Glenister, L and Sharma, N and Wadsley, J and Strachan, M and Chadwich, D and Jayne, D and Stocken, D},
  title = {NIHR NIFTY (ISRCTN:59074092) randomised controlled trial (RCT) results - does near-infrared fluorescence imaging prevent postsurgical hypoparathyroidism after thyroid surgery?},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_3},
  doi = {10.1093/bjs/znag045.013}
}
Kostenlos starten →